How do I buy McKesson (MCK) stock?

Buying McKesson (MCK) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "MCK", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy MCK by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if MCK is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

McKesson (MCK) Stock

Q: What is the minimum investment for MCK on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in McKesson from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · MCK

Trade MCK

Key stats

Market cap: $123.77B
Price / Earnings ratio: 26.3x
EPS (TTM): $38.99
Volume: Loading
52-week high: $1073.95
52-week low: $723.68
Dividend yield: 0.32%
Dividend amount (latest): $0.94
EPS vs analyst estimate: +9.6%Q2 FY26 · $9.86 vs $9.00

Source: third-party data provider, as of November 7, 2026

EPS estimate: analyst consensus

Compare with MCK

Technical indicators

RSI 14: 74.31
MACD 12/26/9: 30.13
EMA 9 of MACD: 25.88
MACD histogram: 4.25
SMA 50: $934.29; Price above SMA 50
EMA 50: $945.61; Price above EMA 50
SMA 200: $866.68; Price above SMA 200
EMA 200: $880.81; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 5, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Buy

Based on 8 analyst ratings

Strong Sell0

Sell0

Hold3

Buy5

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2022

2023

2024

2025

2026

484B320B160B0

Debt & Balance Sheet

Total assets

Total liabilities

2022

2023

2024

2025

2026

101B67B33B0

Revenue to Profit

2026

$403.4B

Revenue

$0.0

Cost of revenue

$14.6B

Gross profit

$0.0

Operating expenses

$4.8B

Net income

Earnings

EPS forecast

Actual EPS

$9.86

$9.00

Q2FY26

$9.24

Q3FY26

$11.30

Q4FY26

$9.64

Q1FY27

$10.72

Q2FY27

The market is expecting earnings per share of $10.72 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About McKesson

We are a global leader in healthcare supply chain management solutions, retail pharmacy, healthcare technology, community oncology and specialty care. We partner with life sciences companies, manufacturers, providers, pharmacies, governments and other healthcare organizations to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost effectively.

SectorHealthcare

IndustryMedical Distribution

Employees41,600

CEOMr. Brian S. Tyler Ph.D.

IPO DateNov 15, 1994

HeadquartersIrving, TX

Key Executives

Name	Title	Year Born
Mr. Brian S. Tyler Ph.D.	CEO & Chairman	1967
Mr. Kenny K. Cheung	Executive VP & CFO	1982
Ms. Michele Lau J.D.	Executive VP & Chief Legal Officer	1976
Ms. LeAnn B. Smith	Executive VP & Chief Human Resources Officer	1975
Mr. Napoleon B. Rutledge Jr.	Senior VP, Controller & Chief Accounting Officer	1973
Paula Adkison	Senior Vice President of Corporate Finance, Investor Relations & Strategic Finance	—
Mr. Francisco J. Fraga	Executive VP, Chief Information Officer & CTO	1973
Ms. Jeni Dominguez	Head of Investor Relations	—
Mr. Kirk Kaminsky	Executive VP & Group President of North American Pharmaceutical Services	—
Mr. Stanton J. McComb	President of Medical-Surgical	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-1.6	+15.4
2022	+3.5	+7.0	+12.7	+0.9	+7.1	+1.2	+3.7	+7.2	-6.6	+12.3	-0.1	-1.2
2023	+1.2	-5.7	+1.2	+0.1	+10.4	+9.8	-4.4	+1.8	+5.5	+4.1	+2.4	-0.4
2024	+5.6	+3.9	+2.1	+0.1	+7.2	+1.9	+5.2	-10.8	-13.9	+0.4	+19.4	-8.3
2025	+5.0	+6.7	+4.4	+5.8	+1.8	+1.5	-4.7	-1.7	+11.7	+6.0	+7.4	-4.3
2026	+0.9	+16.6	-12.7	-6.5	-8.8	+2.8	+11.5	+7.0	-5.8	+10.7	+7.4

Stocks in the same sector

FAQ

Buying McKesson (MCK) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "MCK", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy MCK by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in McKesson from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, McKesson regularly pays dividends to shareholders. Currently, the estimated dividend yield for MCK is around 0.32% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

McKesson (MCK) Stock

Key stats

Compare with MCK

Recent news

Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?

Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?

Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?

Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?

Stay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key Metrics

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?

Wall Street Bulls Look Optimistic About McKesson (MCK): Should You Buy?

Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?

Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?

Stay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key Metrics

Stay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key Metrics

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

Why McKesson (MCK) is a Top Growth Stock for the Long-Term

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

McKesson (MCK) Earnings Expected to Grow: Should You Buy?